1. Home
  2. RCKT vs CIGL Comparison

RCKT vs CIGL Comparison

Compare RCKT & CIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.04

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

CIGL

Concorde International Group Ltd Class A Ordinary Shares

HOLD

Current Price

$1.99

Market Cap

417.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCKT
CIGL
Founded
1999
1997
Country
United States
Singapore
Employees
202
134
Industry
Biotechnology: Pharmaceutical Preparations
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
401.6M
417.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RCKT
CIGL
Price
$3.04
$1.99
Analyst Decision
Buy
Analyst Count
14
0
Target Price
$29.73
N/A
AVG Volume (30 Days)
2.0M
68.1K
Earning Date
05-04-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$64.28
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$1.40
52 Week High
$5.45
$25.00

Technical Indicators

Market Signals
Indicator
RCKT
CIGL
Relative Strength Index (RSI) 38.89 56.54
Support Level $2.96 $1.55
Resistance Level $3.52 $2.28
Average True Range (ATR) 0.19 0.16
MACD -0.01 0.01
Stochastic Oscillator 19.27 69.49

Price Performance

Historical Comparison
RCKT
CIGL

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

About CIGL Concorde International Group Ltd Class A Ordinary Shares

Concorde International Group Ltd is an integrated security services provider that combines physical manpower and technology to deliver effective security solutions. The company offers a range of services to enhance security and safety: (1) i-Guarding Services; (2) Man-Guarding Services; and (3) Consultancy and Training Services. Its i-Guarding Services leverages technology to increase efficiency, with a mobile platform and cluster aggregation model of a higher skillset workforce. It has two operating segments, which are (i) security services; and (ii) training school. Key revenue is generated from Security Services.

Share on Social Networks: